Literature DB >> 30517642

Insights Into Local Orbital Immunity: Evidence for the Involvement of the Th17 Cell Pathway in Thyroid-Associated Ophthalmopathy.

Sijie Fang1,2,3,4, Yazhuo Huang1,2,3,4, Ningjian Wang5, Shuo Zhang1,2, Sisi Zhong1,2, Yinwei Li1,2, Jing Sun1,2, Xingtong Liu1,2, Yang Wang1,2, Ping Gu1,2, Bin Li2,3,4, Huifang Zhou1,2, Xianqun Fan1,2.   

Abstract

CONTEXT: Unique features of local immunity in thyroid-associated ophthalmopathy (TAO) may affect disease progression.
OBJECTIVE: To investigate the association between the orbital immune microenvironment and TAO development. DESIGN/SETTING/PARTICIPANTS: TAO and control orbital connective tissues were collected. MAIN OUTCOME MEASURES: Single-cell sequencing examined orbital lymphocytic infiltrates. Multicolor flow cytometry explored the phenotypes of different cell subsets and in vitro models for cell functional studies. Coculture experiment and western blotting assay were used to determine underlying mechanism of the enhanced T helper 17 (Th17) cell pathway.
RESULTS: The TAO orbital microenvironment was composed of natural killer cells, dendritic cells, macrophages, T cells, plasma cells, and CD34+ orbital fibroblasts, but few B cells. Increases in CD3+CD8- IL-17A-producing and RAR-related orphan receptor (ROR)γt-expressing T cells and in CD3+CD8- IL-13-producing and GATA3-expressing T cells suggested Th17 and Th2 cell responses in TAO orbits. Increased interferon-γ (IFN-γ)-producing and RORγt+Tbet+ T cells indicated a Th1-like phenotype of orbital-infiltrating Th17 cells. Higher IL-23R and IL-1R expression and lower IL-21R expression were also observed on Th17 cells in TAO orbits. Multivariate analyses revealed that the Th17 pathway [IL-17A (P = 0.001), IFN-γ (P = 0.009), RORγt (P = 0.003), IL-23R (P = 0.033), IL-21R (P = 0.019)], and Th2 pathway [IL-13 (P = 0.015), GATA3 (P = 0.012)] were associated with TAO. IL-17A, IL-23R, and IL-1R correlated with clinical activity score and visual acuity. CD34+ orbital fibroblasts exhibited distinct cell surface marker expression and promoted IL-23R and IL-1R expression on T cells to facilitate the Th17-cell phenotype through prostaglandin E2-EP2/EP4-cAMP signaling.
CONCLUSION: Our study addresses the importance of retroorbital immunity and suggests possible means of disrupting TAO pathogenesis.
Copyright © 2019 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30517642     DOI: 10.1210/jc.2018-01626

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

Review 1.  Immunohistochemical analysis of human orbital tissue in Graves' orbitopathy.

Authors:  Y P Hai; A C H Lee; L Frommer; T Diana; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2019-09-19       Impact factor: 4.256

2.  Teprotumumab Divergently Alters Fibrocyte Gene Expression: Implications for Thyroid-associated Ophthalmopathy.

Authors:  Roshini Fernando; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

Review 3.  2021 update on thyroid-associated ophthalmopathy.

Authors:  E J Neag; T J Smith
Journal:  J Endocrinol Invest       Date:  2021-08-20       Impact factor: 5.467

4.  Editorial: Mechanisms and Novel Therapies in Graves' Orbitopathy: Current Update.

Authors:  Huifang Zhou; Ilaria Muller; Kelvin Kam-Lung Chong; Marian Ludgate; Sijie Fang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-29       Impact factor: 6.055

5.  Novel Approaches for Immunosuppression in Graves' Hyperthyroidism and Associated Orbitopathy.

Authors:  Alan Chun Hong Lee; George J Kahaly
Journal:  Eur Thyroid J       Date:  2020-08-10

6.  Immunological Features of Paranasal Sinus Mucosa in Patients with Graves' Orbitopathy.

Authors:  Yi Lu; Yu Wu; Yazhuo Huang; Sijie Fang; Yinwei Li; Jing Sun; Huifang Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-10       Impact factor: 5.555

Review 7.  Cytokines that Modulate the Differentiation of Th17 Cells in Autoimmune Uveitis.

Authors:  Kailei Guo; Xiaomin Zhang
Journal:  J Immunol Res       Date:  2021-03-16       Impact factor: 4.818

8.  Evaluating the Role of Circulating Dendritic Cells in Methimazole-Treated Pediatric Graves' Disease Patients.

Authors:  Aleksandra Starosz; Karolina Stożek; Marcin Moniuszko; Kamil Grubczak; Artur Bossowski
Journal:  Genes (Basel)       Date:  2021-01-26       Impact factor: 4.096

9.  A novel CD4+ CTL subtype characterized by chemotaxis and inflammation is involved in the pathogenesis of Graves' orbitopathy.

Authors:  Yue Wang; Ziyi Chen; Tingjie Wang; Hui Guo; Yufeng Liu; Ningxin Dang; Shiqian Hu; Liping Wu; Chengsheng Zhang; Kai Ye; Bingyin Shi
Journal:  Cell Mol Immunol       Date:  2021-01-29       Impact factor: 11.530

Review 10.  Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy.

Authors:  Sijie Fang; Yi Lu; Yazhuo Huang; Huifang Zhou; Xianqun Fan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-01       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.